PI
AZN icon

Placemark Investments’s AstraZeneca AZN Stock Holding History

Placemark Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$4.46M Buy
63,451
+1,366
+2% +$97.8K 0.08% 319
2014
Q3 		$4.43M Buy
62,085
+2,714
+5% +$199K 0.08% 299
2014
Q2 		$4.41M Sell
59,371
-69,381
-54% -$5.02M 0.08% 312
2014
Q1 		$8.36M Sell
128,752
-129,662
-50% -$8.37M 0.16% 141
2013
Q4 		$15.3M Buy
258,414
+69,243
+37% +$3.76M 0.25% 85
2013
Q3 		$9.82M Buy
189,171
+12,838
+7% +$645K 0.19% 131
2013
Q2 		$8.34M Buy
+176,333
New +$8.98M 0.18% 146

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Placemark Investments's AZN Position: Q4 2014 in Review

Placemark Investments increased its AstraZeneca (AZN) stake by 2.2% in Q4 2014, buying an estimated $97.8K and bringing the position to 63,451 shares worth $4.46M. The position accounts for 0.08% of the portfolio, ranked #319.

Placemark Investments first reported a position in AZN in Q2 2013 and has held it in 7 quarters since. The position peaked at $15.3M in Q4 2013. 404 funds tracked by Wall St. Rank hold AZN as of Q4 2014.

  • Placemark Investments held 63,451 shares of AstraZeneca worth $4.46M as of Q4 2014.
  • Placemark Investments bought 1,366 AstraZeneca shares in Q4 2014, an estimated $97.8K.
  • AstraZeneca made up 0.08% of Placemark Investments's portfolio in Q4 2014, its #319 holding.
  • Placemark Investments first reported a position in AstraZeneca in Q2 2013 and has held it in 7 quarters since.
  • Placemark Investments's AstraZeneca position peaked at $15.3M in Q4 2013.
  • 404 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.